Search alternatives:
marked decrease » marked increase (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
marked decrease » marked increase (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…<p>(A) Representative images showed calcium deposition (red). (B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
8
-
9
Associations between characteristics of Stories for Change Diabetes participants and meaningful decrease in hemoglobin A1c (HbA1c) from baseline to 3 months (N = 227)....
Published 2025“…<p>Associations between characteristics of Stories for Change Diabetes participants and meaningful decrease in hemoglobin A1c (HbA1c) from baseline to 3 months (N = 227).…”
-
10
-
11
-
12
-
13
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…Summarized bar graphs showed EVO significantly decreased mRNA expression of pyroptotic markers (B) NLRP3 and (C) GSDM-D in CER treated P<sub>i</sub>-induced VSMCs. …”
-
14
-
15
-
16
-
17
-
18
-
19
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
20